Oppenheimer & Co’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Oppenheimer & Co’s Portfolio IBDS Stock Details IBDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$776K	Sell	32,040 -6,254	-16%	-$151K	0.01%	1054
2026 Q1	$928K	Buy	38,294 +1,862	+5%	+$45.2K	0.01%	900
2025 Q4	$885K	Buy	36,432 +1,958	+6%	+$47.6K	0.01%	852
2025 Q3	$839K	Buy	34,474 +714	+2%	+$17.3K	0.01%	976
2025 Q2	$819K	Sell	33,760 -121	-0.4%	-$2.92K	0.01%	948
2025 Q1	$819K	Buy	33,881 +2,411	+8%	+$58K	0.01%	886
2024 Q4	$754K	Buy	31,470 +2,994	+11%	+$72.1K	0.01%	912
2024 Q3	$694K	Buy	+28,476	New	+$686K	0.01%	914

Other funds holding IBDS

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Mercer Global Advisors Denver, Colorado $80.9B AUM 26.08% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

HPC

HM Payson & Co Portland, Maine $7.54B AUM 31.34% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

SVWAG

Sound View Wealth Advisors Group Savannah, Georgia $1.61B AUM 26.11% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $7.59B AUM 23.38% 1-Year Est. Return

Oppenheimer & Co's IBDS Position: Q2 2026 in Review

Oppenheimer & Co reduced its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 16% in Q2 2026, selling an estimated $151K and leaving 32,040 shares worth $776K. The position accounts for 0.01% of the portfolio, ranked #1054.

Oppenheimer & Co first reported a position in IBDS in Q3 2024 and has held it in 8 quarters since. The position peaked at $928K in Q1 2026. 416 funds tracked by Wall St. Rank hold IBDS as of Q2 2026.

Oppenheimer & Co held 32,040 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $776K as of Q2 2026.
Oppenheimer & Co sold 6,254 iShares iBonds Dec 2027 Term Corporate ETF shares in Q2 2026, an estimated $151K.
iShares iBonds Dec 2027 Term Corporate ETF made up 0.01% of Oppenheimer & Co's portfolio in Q2 2026, its #1054 holding.
Oppenheimer & Co first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q3 2024 and has held it in 8 quarters since.
Oppenheimer & Co's iShares iBonds Dec 2027 Term Corporate ETF position peaked at $928K in Q1 2026.
416 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2026.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.